These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28625271)

  • 21. Immune Checkpoints: Novel Therapeutic Targets to Attenuate Sepsis-Induced Immunosuppression.
    McBride MA; Patil TK; Bohannon JK; Hernandez A; Sherwood ER; Patil NK
    Front Immunol; 2020; 11():624272. PubMed ID: 33613563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The protective role of autophagy in sepsis.
    Feng Y; Liu B; Zheng X; Chen L; Chen W; Fang Z
    Microb Pathog; 2019 Jun; 131():106-111. PubMed ID: 30935962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relationship between sepsis-induced immunosuppression and multi-drugs resistant bacteria].
    Cai G; Ye J; Wen M
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Nov; 30(11):1095-1098. PubMed ID: 30541653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autophagy: A Potential Therapeutic Target for Reversing Sepsis-Induced Immunosuppression.
    Ren C; Zhang H; Wu TT; Yao YM
    Front Immunol; 2017; 8():1832. PubMed ID: 29326712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential Immunotherapeutics for Immunosuppression in Sepsis.
    Shin J; Jin M
    Biomol Ther (Seoul); 2017 Nov; 25(6):569-577. PubMed ID: 29081088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genipin attenuates sepsis-induced immunosuppression through inhibition of T lymphocyte apoptosis.
    Kim JS; Kim SJ; Lee SM
    Int Immunopharmacol; 2015 Jul; 27(1):15-23. PubMed ID: 25921028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune Intervention in Sepsis.
    Chen J; Wei H
    Front Pharmacol; 2021; 12():718089. PubMed ID: 34335278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoadjuvant therapy in sepsis: novel strategies for immunosuppressive sepsis coming down the pike.
    Watanabe E; Thampy LK; Hotchkiss RS
    Acute Med Surg; 2018 Oct; 5(4):309-315. PubMed ID: 30338075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sepsis: Updated definitions and optimized management.
    Panknin HT; Schröder S; Trautmann M
    Med Monatsschr Pharm; 2016 Jul; 39(7):299-306. PubMed ID: 29953183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sepsis-induced immune dysfunction: can immune therapies reduce mortality?
    Delano MJ; Ward PA
    J Clin Invest; 2016 Jan; 126(1):23-31. PubMed ID: 26727230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct pathophysiologic mechanisms of septic acute kidney injury: role of immune suppression and renal tubular cell apoptosis in murine model of septic acute kidney injury.
    Lee SY; Lee YS; Choi HM; Ko YS; Lee HY; Jo SK; Cho WY; Kim HK
    Crit Care Med; 2012 Nov; 40(11):2997-3006. PubMed ID: 22878677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment Advances in Sepsis and Septic Shock: Modulating Pro- and Anti-Inflammatory Mechanisms.
    Marques A; Torre C; Pinto R; Sepodes B; Rocha J
    J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Betacaryophyllene - A phytocannabinoid as potential therapeutic modality for human sepsis?
    Meza A; Lehmann C
    Med Hypotheses; 2018 Jan; 110():68-70. PubMed ID: 29317072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesenchymal Stem Cells in Sepsis and Associated Organ Dysfunction: A Promising Future or Blind Alley?
    Horák J; Nalos L; Martínková V; Beneš J; Štengl M; Matějovič M
    Stem Cells Int; 2017; 2017():7304121. PubMed ID: 29098010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Advancement in the research of mechanism of immune dysfunction in sepsis and the regulatory effects of Xuebijing injection].
    Gao YL; Chai YF; Yao YM
    Zhonghua Shao Shang Za Zhi; 2013 Apr; 29(2):162-5. PubMed ID: 23985206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Membrane-camouflaged biomimetic nanoparticles as potential immunomodulatory solutions for sepsis: An overview.
    Wang Y; Liu L; Zheng X; Liu X
    Front Bioeng Biotechnol; 2023; 11():1111963. PubMed ID: 36970623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of cellular events in the pathophysiology of sepsis.
    Bhan C; Dipankar P; Chakraborty P; Sarangi PP
    Inflamm Res; 2016 Nov; 65(11):853-868. PubMed ID: 27392441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change?
    Leentjens J; Kox M; van der Hoeven JG; Netea MG; Pickkers P
    Am J Respir Crit Care Med; 2013 Jun; 187(12):1287-93. PubMed ID: 23590272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current insights in sepsis: from pathogenesis to new treatment targets.
    Wiersinga WJ
    Curr Opin Crit Care; 2011 Oct; 17(5):480-6. PubMed ID: 21900767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological characterization of compensatory anti-inflammatory response syndrome in patients with severe sepsis: a longitudinal study*.
    Gomez HG; Gonzalez SM; Londoño JM; Hoyos NA; Niño CD; Leon AL; Velilla PA; Rugeles MT; Jaimes FA
    Crit Care Med; 2014 Apr; 42(4):771-80. PubMed ID: 24365860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.